Science & Technology
Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy
Department of Health and Human Services — National Institutes of Health
Opportunity #: 1R43DA058430-01
Award Ceiling
$325K
Award Floor
$325K
Close Date
Apr 30, 2024
Total Funding
$325K
Expected Awards
1
Posted Date
May 1, 2023
Cost Sharing Required
No
Grants.gov ID
sbir-1R43DA058430-01
Description
SBIR Phase Phase I award: "Predicting and Preventing Adverse Maternal and Child Outcomes of Opioid Use Disorder in Pregnancy" awarded to OpalGenix, Inc. in Carmel, Indiana. Funded by Department of Health and Human Services (National Institutes of Health). Award amount: $325,239. The SBIR/STTR programs fund innovative research and development by small businesses, with Phase I for feasibility studies and Phase II for full R&D.
Eligible Applicants
Small businesses
Apply on Grants.gov
Always verify details and apply through the official Grants.gov portal. Information here may not reflect the latest changes.
View on Grants.govDisclaimer: This information is sourced from Grants.gov and may not reflect the most current details. Always verify eligibility requirements, deadlines, and application procedures on the official program website before applying.